论文部分内容阅读
目的 探讨强肝胶囊联合丹参注射液治疗慢性肝纤维化的疗效。方法 强肝胶囊 5粒 ,口服 ,Bid× 8周 ,丹参注射液3 0mL加入 10 %葡萄糖注射液 2 5 0mL ,静滴 ,qd× 8周 ,肝力新注射液 2 5 0mL ,静滴 ,qd× 8周 ;对照组应用灯盏花注射液 3 0mL加入10 %葡萄糖注射液 2 5 0mL ,静滴 ,qd× 8周 ,肝力新注射液 2 5 0mL静滴 ,qd× 8周。主要观察二组治疗前后血清肝纤维化指标的变化。结果 二组治疗后血清肝纤维化指标均较治疗前下降 (P <0 .0 5 ) ,二组治疗后对比有显著差异 (P <0 .0 1,P <0 .0 5 )。结论 强肝胶囊联合丹参注射液抗肝纤维化治疗有较好的疗效。
Objective To investigate the therapeutic effect of Qianggan capsule combined with Danshen injection on chronic liver fibrosis. Methods Qianggan capsule 5, orally, bid × 8 weeks, Danshen injection 30mL added 10% glucose injection 250mL, intravenous drip, qd × 8 weeks, liver new injection 250mL, intravenous infusion, qd × 8 weeks. The control group was treated with 30 milligrams of Erigeron breviscapus injection, 250 mL of 10% glucose injection, intravenous drip, qd × 8 weeks, intravenous infusion of 250mg of Hepatic New Injection, qd × 8 weeks. The main observation of two groups before and after treatment of serum liver fibrosis index changes. Results The indexes of serum liver fibrosis of the two groups after treatment were lower than those before treatment (P <0.05). There was significant difference between the two groups after treatment (P <0.01, P <0.05). Conclusion Qianggan capsule combined with Danshen injection anti-liver fibrosis treatment has a good effect.